Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection
Clinical trial NCT00062660 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT00062660
- Sponsor
- Boehringer Ingelheim
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
- Start date
- 2003-05-01
- Primary completion
- 2014-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.